| Name | JBI-589 |
|---|
| Description | JBI-589 is a non-covalent PAD4 isoform-selective inhibitor. JBI-589 reduces CXCR2 expression and blocks neutrophil chemotaxis. JBI-589 reduces primary tumor and metastases, and enhances the anti-tumor effect of checkpoint inhibitors[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H28FN5O |
|---|---|
| Molecular Weight | 481.56 |